Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

NCT02638701 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02638701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02638701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 1, 2024
Completion date
December 31, 2028
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm, stroke, tumor necrosis factor-alpha, vasculitis